Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy?
David Paez, Laia Paré, Iñigo Espinosa, Juliana Salazar, Elisabeth Del Rio, Agustí Barnadas, Eugenio Marcuello, Montserrat BaigetVolume:
101
Year:
2010
Language:
english
Pages:
6
DOI:
10.1111/j.1349-7006.2010.01621.x
File:
PDF, 178 KB
english, 2010